


AMG Weight Loss Center in Gastonia, North Carolina, operates under the medical direction of Dr. Eric Ibegbu, a board-certified gastroenterologist and ASGE Star Certified Endoscopist who applies his specialized training in digestive health to comprehensive weight management. The clinic's foundation in gastroenterology informs its approach to metabolic dysfunction, recognizing that sustainable weight loss requires addressing underlying digestive and hormonal factors rather than relying solely on caloric restriction. Dr. Ibegbu's dual expertise allows the practice to offer both medical weight loss interventions and advanced endoscopic procedures within a single clinical setting, providing continuity of care for patients whose obesity intersects with gastrointestinal conditions.
The center's pharmacological weight loss protocols center on three FDA-approved GLP-1 receptor agonists: semaglutide, tirzepatide, and liraglutide. Semaglutide therapy at AMG Weight Loss Center follows evidence-based dosing schedules that begin at 0.25 mg weekly and titrate upward based on individual tolerance and response, with patients typically reaching maintenance doses between 1.7 mg and 2.4 mg. Tirzepatide represents the clinic's dual GIP/GLP-1 agonist option, offering enhanced glycemic control for patients with concurrent type 2 diabetes while producing average weight reductions that exceed single-pathway medications in clinical trials. Liraglutide provides an alternative for patients who require daily dosing flexibility or have contraindications to weekly injectable formulations. Each peptide protocol includes baseline metabolic panels, thyroid function assessment, and lipase monitoring to ensure safe administration and identify patients who may benefit from adjunctive interventions.
Dr. Ibegbu's gastroenterology credentials extend beyond peptide prescribing to include endoscopic sleeve gastroplasty (ESG), a non-surgical stomach reduction procedure that the clinic offers as an alternative to bariatric surgery. This endoscopic technique uses full-thickness suturing to reduce gastric volume by approximately 70 percent, creating restriction without incisions or permanent anatomical changes. Patients considering ESG at the Gastonia location undergo comprehensive pre-procedure evaluation including upper endoscopy, nutritional assessment, and psychological screening to determine candidacy. The combination of ESG availability and medical weight loss options allows Dr. Ibegbu to stratify treatment intensity based on BMI, comorbidity burden, and previous weight loss attempts, offering liraglutide or semaglutide for patients with BMI between 27 and 35, while reserving tirzepatide and endoscopic intervention for those with higher baseline weights or inadequate response to initial therapy.
Patients at AMG Weight Loss Center receive in-person consultations at the Gastonia facility, where initial visits include body composition analysis, review of weight history and previous attempts, assessment of obesity-related comorbidities such as sleep apnea and fatty liver disease, and discussion of realistic timelines for medication-assisted weight loss. Follow-up appointments occur monthly during the titration phase of peptide therapy, then transition to quarterly visits once patients reach stable dosing. The clinic's protocols require documentation of dietary intake and physical activity patterns, not as punitive measures but as data points that help Dr. Ibegbu identify metabolic adaptation or medication tolerance issues that may necessitate dose adjustment or combination therapy. Patients who develop gastrointestinal side effects from GLP-1 agonists benefit from Dr. Ibegbu's gastroenterology background, as he can distinguish between expected medication effects and underlying conditions such as gastroparesis or bile reflux that require separate intervention.
The practice's location in Gastonia positions it to serve patients throughout the Charlotte metropolitan area and western North Carolina communities where access to physician-supervised weight loss programs remains limited. AMG Weight Loss Center's integration of peptide therapy with endoscopic capabilities differentiates it from medspas and telehealth-only providers that lack the procedural infrastructure to escalate treatment when medications alone prove insufficient. Dr. Ibegbu's ASGE Star Certification—a designation requiring demonstrated proficiency in complex endoscopic techniques and commitment to quality metrics—provides assurance that both diagnostic and therapeutic procedures meet national benchmarks for safety and effectiveness. For North Carolina residents seeking medical weight loss guided by a physician with advanced procedural training rather than a prescriber operating outside their scope of practice, the clinic offers a model where peptide therapy exists within a broader framework of metabolic and digestive health management.
Dr. Eric Ibegbu· Board Certified Gastroenterologist
Dr. Eric Ibegbu, MD
Endobariatric Gastroenterologist
Dr. Eric Ibegbu is a distinguished Endobariatric Gastroenterologist renowned for compassionate care and unparalleled expertise. He specializes in Advanced Gastroenterology, Non-surgical weight loss procedures and body contouring procedures.
Topics Mentioned in Reviews
Endoscopic Sleeve Gastroplasty
A minimally invasive, outpatient, non-surgical, incision-less weight loss procedure.
Bariatric Revision
A non-surgical procedure designed to improve quality of life for patients who have regained weight after a gastric bypass procedure.
Spatz 3
A gastric balloon system for weight loss.
Orbera Gastric Balloon
A non-surgical weight loss solution using a gastric balloon.
Weightloss Medications
Medications prescribed for weight loss management.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.
